Cognition Therapeutics, Inc.
CGTX
$1.01
-$0.03-2.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.93M | -4.57M | -3.34M | -4.93M | -6.73M |
| Total Depreciation and Amortization | 55.00K | 68.00K | 61.00K | 61.00K | 61.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 298.00K | 335.00K | 399.00K | 522.00K | 621.00K |
| Change in Net Operating Assets | 526.00K | -1.38M | -554.00K | -1.30M | 429.00K |
| Cash from Operations | -3.05M | -5.54M | -3.44M | -5.65M | -5.62M |
| Capital Expenditure | -20.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 9.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -20.00K | -- | 9.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -116.00K | -113.00K | -74.00K | -41.00K | -120.00K |
| Issuance of Common Stock | 6.74M | 44.00K | 3.00M | 33.99M | 877.00K |
| Repurchase of Common Stock | -11.00K | -164.00K | -77.00K | -36.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2.25M | -- | -- |
| Cash from Financing | 6.61M | -233.00K | 605.00K | 33.92M | 752.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.54M | -5.78M | -2.82M | 28.27M | -4.87M |